Authors
Nezhuvaka I.A., Fayzrakhmanov R.R., Shishkin M.M.
Pirogov National Medical and Surgical Center, Moscow
Abstract
Aim. To summarize current domestic and foreign data on biomarkers of the aqueous humor in neovascular glaucoma (NVG). To evaluate their role in pathogenesis, as well as diagnostic, prognostic, and therapeutic significance.
Materials and Methods. A systematic review of the literature on the cytokine profile in the intraocular fluid in NVG was performed. The results of a meta-analysis of 24 studies (771 patients with NVG and 727 controls) and data from modern proteomic works were analyzed. Russian studies were separately studied, including the works of Konovalova K.I. et al. on the cytokine profile in proliferative diabetic retinopathy. The search was conducted in PubMed, Scopus, Web of Science, and eLibrary from 2010 to 2026.
Results. The meta-analysis revealed a pronounced cytokine imbalance in the aqueous humor in NVG. Levels of VEGF (SMD = 8.79), IL-6 (SMD = 12.50), IL-8 (SMD = 3.99), TNF-α (SMD = 3.37), EPO (SMD = 9.62), and PlGF (SMD = 2.62) were elevated. PEDF level was decreased (SMD = -3.03). Proteomic analysis identified 2255 proteins, 20 of which were significantly altered in NVG. Pro-inflammatory cytokines (IL-6, IL-8, MCP-1) are associated with unfavorable surgical outcomes. An inverse correlation between VEGF and PEDF was found. Russian studies confirm the key role of VEGF-A in the progression of diabetic retinopathy and the development of NVG. The involvement of IL-8 and MCP-1 in the pathogenesis of proliferative diabetic retinopathy is shown.
Conclusions. NVG is characterized by a specific cytokine profile: an increase in VEGF, IL-6, IL-8 against the background of a decrease in PEDF. VEGF and PEDF are key markers of angiogenic imbalance and promising therapeutic targets. Pro-inflammatory cytokines make a significant contribution to pathogenesis and determine the prognosis of surgical treatment. The Russian evidence base on biomarkers in NVG is limited. This requires further multicenter studies.
Keywords: neovascular glaucoma, aqueous humor, biomarkers, VEGF, PEDF, interleukins, proteomic analysis, cytokine profile, angiogenesis, inflammation, NLRP3.
References
1. Glaukomy` vtorichny`e u vzrosly`x: klinicheskie rekomendacii. M.; 2025. (In Russ.)
2. Sivak-Callcott JA, O’Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001; 108(10): 1767-1776.
3. Simha A, Aziz K, Braganza A, et al. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2020; 2(2): CD007920.
4. Tombran-Tink J, Barnstable CJ. PEDF: a multifaceted neurotrophic factor. Nat Rev Neurosci. 2003; 4(8): 628-636.
5. Wang JW, Zhou MW, Zhang XL, et al. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma. Clin Exp Ophthalmol. 2015; 43(5): 415-421.
6. Ohira S, Inoue T, Shobayashi K, et al. Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection. Invest Ophthalmol Vis Sci. 2015; 56(6): 3541-3548.
7. Gachette RE, Bertens CJF, Gijs M, Beckers HJM. Fibrosis-Associated Fluid Biomarkers for Predicting Surgical Outcomes in Glaucoma Surgery: A Systematic Review. Curr Eye Res. 2026; 51(7): 741-751.
8. Kiełbus M, Kuźmiuk D, Skrzyniarz AM, et al. Changes in the Protein Composition of the Aqueous Humor in Patients with Glaucoma: An Update Review. Int J Mol Sci. 2025; 26(7): 3129.
9. Mok JH, Park DY, Han JC. Differential protein expression and metabolite profiling in glaucoma: Insights from a multi-omics analysis. Biofactors. 2024; 50(6):1220-1235.
10. Oh JW, Ahn SJ, Jung JH, et al. Proteomic Analysis of Aqueous Humor Identified Clinically Relevant Molecular Targets for Neovascular Complications in Diabetic Retinopathy. Mol Cell Proteomics. 2025; 24(4): 100953.
11. Zhu S, Chen J, Zhou M, et al. Cytokines expression in intraocular fluid in neovascular glaucoma: a meta-analysis. Chin J Exp Ophthalmol. 2024; 42(6): 538-546.
12. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003; 9(6): 669-676.
13. Zhou M, Wang J, Wang W, et al. Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab Injection. PLoS One. 2016; 11(1): e0146993.
14. Midena E, Bini S, Frizziero L, et al. Aqueous humour concentrations of PEDF and Erythropoietin are not influenced by subthreshold micropulse laser treatment of diabetic macular edema. Biosci Rep. 2019; 39(6): BSR20190328.
15. Konovalova KI, Shishkin MM, Fayzrakhmanov RR. Evaluation of the level of pro- and anti-inflammatory cytokines in two-stage vitreoretinal surgery in patients with advanced proliferative diabetic retinopathy. Russian Ophthalmological Journal. 2021; 14(3): 14–18. (In Russ.)
16. Konovalova KI, Shishkin MM, Fayzrakhmanov RR, et al. The role of cytokines in the pathogenesis of proliferative diabetic retinopathy. Point of View. East – West. 2025; 12(2): 43–48. (In Russ.)


